LENMELDY™ is the first and only disease-modifying intravenous infusion proven to extend life expectancy in pre-symptomatic late infantile (PSLI) patients…
First Institutional Trade Successfully Executed The New UK Trading Venue Brings Institutional-Grade Market Infrastructure, Central Clearing, and Deep Liquidity to…